Work

Institutional and national budget impact of alternative pembrolizumab dosing in non-small cell lung cancer: a real-world pharmacoeconomic analysis

Year: 2026

Type: article

Source: Expert Review of Pharmacoeconomics & Outcomes Research

DOI: 10.1080/14737167.2026.2717291

Authors: Igor Rubinić, Robert Likić, Marina Paladin, Nataša Skočibušić, Ines Mujčin, Ivana Mikolašević, Vera Vlahović-Palčevski

Institutions: University of Rijeka, Klinički Bolnički Centar Rijeka, University Hospital Centre Zagreb, University of Zagreb

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7203721430

FWCI:

Cites: 30

Cited by:

Related to: